Hively Brad

Hively Brad is listed in filings as Director at The Oncology Institute, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including sale activity and purchase activity. Recent filings connect the profile to The Oncology Institute, Inc. (TOIIW) and The Oncology Institute, Inc. (TOI). The current snapshot covers public activity from Jun 20, 2024 to Dec 16, 2025. Reported amounts are shown as $50.3K to $5.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.